Skip to main content
Premium Trial:

Request an Annual Quote

Biocept Liquid Biopsy ROS1 Assay

Biocept announced it has launched a blood-based ROS1 rearrangement test for non-small cell lung cancer patients. The assay, which will be performed at the firm's CLIA-certified and CAP-accredited laboratory, detects ROS1 rearrangements in circulating tumor cells in order to determine if NSCLC patients might benefit from molecularly targeted drugs.

The Scan

J&J Booster Support

A US Food and Drug Administration advisory panel has voted to support a booster dose of Johnson & Johnson's SARS-CoV-2 vaccine, according to the Los Angeles Times.

To Keep the Cases Moving

The president of the UK Royal College of Pathologists tells the Financial Times that more investment is needed to tackle a backlog of cases.

NAS Expels Archaeologist

Science reports Luis Jaime Castillo Butters' expulsion is the first of an international member from the US National Academy of Sciences.

PLOS Papers on Angelman Syndrome-Like Cases, Salmonella Paratyphi A, SARS-CoV-2 in Brazil

In PLOS this week: exome sequencing analysis of Angelman syndrome-like cases, genetic epidemiology of Salmonella Paratyphi A, and more.